Susquehanna International Group, LLP Neuro Pace Inc Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$9.78 - $17.5 $1.58 Million - $2.83 Million
161,491 Added 381.91%
203,776 $2.69 Million
Q4 2023

Feb 14, 2024
BUY
$5.9 - $10.31 $249,481 - $435,958
42,285 New
42,285 $435,000
Q1 2023

May 16, 2023
BUY
$1.44 - $5.34 $20,234 - $75,037
14,052 New
14,052 $65,000

Others Institutions Holding NPCE

# of Institutions
53
Shares Held
20.9M
Call Options Held
1.3K
Put Options Held
100
View Full List

About NeuroPace Inc

NPCE Quotes by TradingView
  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $371M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email